Hiemcke-JiwaLSMeisterMTMartinE, et al.NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target. Acta Neuropathol. 2023;145(1):149-152.
2.
FerraraRAugerNAuclinEBesseB. Clinical and translational implications of RET rearrangements in non-small cell lung cancer. J Thorac Oncol. 2018;13(1):27-45.
3.
GautschiOMiliaJFilleronT, et al.Targeting RET in patients with RET-rearranged lung cancers: results from the global, multicenter RET registry. J Clin Oncol. 2017;35(13):1403-1410.
4.
Ambrosini-SpaltroAFarnediACalistriD, et al.The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies’ integration. Hum Pathol. 2022;123:20-30.
5.
AntonescuCRDicksonBCSwansonD, et al.Spindle cell tumors with RET gene fusions exhibit a morphologic spectrum akin to tumors with NTRK gene fusions. Am J Surg Pathol. 2019;43(10):1384-1391.
6.
KaoYCSuurmeijerAJHArganiP, et al.Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern. Genes Chromosomes Cancer. 2020;59(10):575-583.
7.
WeismanPSAltinokMCarballoEV, et al.Uterine cervical sarcoma with a novel RET-SPECC1L fusion in an adult: a case which expands the homology between RET-rearranged and NTRK-rearranged tumors. Am J Surg Pathol. 2020;44(4):567-570.
8.
ZhouYQiCXiaoMZCaiSLChenBJ. RASAL2-RET: a novel RET rearrangement in a patient with high-grade sarcoma of the chest. Ann Oncol. 2020;31(5):659-661.
9.
KoelscheCSchrimpfDStichelD, et al.Sarcoma classification by DNA methylation profiling. Nat Commun. 2021;12(1):498.
10.
MorganGJHeJTytarenkoR, et al.Kinase domain activation through gene rearrangement in multiple myeloma. Leukemia. 2018;32(11):2435-2444.
